1 / 5

Cancer Drug Industry Forecast and Size Analysis 2019-2025

Global Cancer Drug Industry was valued at USD 73.40 Billion in the year 2017. Global Cancer Drug Industry is further estimated to grow at a CAGR of 7.98% from 2018 to 2025 to reach USD 135.71 Billion by the year 2025. North America region holds the highest Industry share in 2017 with APAC region is considered as the fastest growing Industry in the forecasted period. At a country level, the U.S is the biggest Industry in 2017 and it is projected to grow at a gradual pace in the coming years.<br>

marketupdates01
Download Presentation

Cancer Drug Industry Forecast and Size Analysis 2019-2025

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Cancer Drug Industry Forecast and Size Analysis 2019-2025 Global Cancer Drug Industry was valued at USD 73.40 Billion in the year 2017. Global Cancer Drug Industry is further estimated to grow at a CAGR of 7.98% from 2018 to 2025 to reach USD 135.71 Billion by the year 2025. North America region holds the highest Industry share in 2017 with APAC region is considered as the fastest growing Industry in the forecasted period. At a country level, the U.S is the biggest Industry in 2017 and it is projected to grow at a gradual pace in the coming years. The major market players in Cancer Drug Industry are Roche Holdings Inc., Johnson & Johnson, Novartis AG, Celgene, Eli Lilly and Company, Pfizer, Celgene Corporation, Sanofi, Merck & Co., Amgen Inc. (Other 13 companies detailed information is provided in research report). Roche Diagnostics holds the substantial Industry share because of its better global presence both at production and at an operational level. Rising research and development expenses to cater changing demand of end users, similarly, growth strategies such as acquisition, merger, and expansion of the distribution network were few techniques adopted by most of Tier 1 and Tier 2 manufacturers in recent years. Request Sample Copy of this Market Research Report @ https://www.alexareports.com/report-sample/9274 SWOT Analysis of Cancer Drugs Industry Strength Growing incidence and pervasiveness of various types of cancer Academic alliances and partnerships Weakness

  2. Side-effects of anti-cancer drug therapy The high cost of drug development and a threat of failure Opportunity Scientific advancements in treatment methods Increasing focus on personalized Anti-cancer medicine Threats Patent Cliff The Immunotherapy segment in the global Cancer Drug Industry is expected to hold the highest Industry share during the forecast period. The growth can be attributed to growing areas within oncology R&D, high efficacy and fewer side effects and unique molecular level targeting. On the other hand, Blood Cancer by the application is expected to grow at the highest CAGR during the year 2018-2025. Majorly due to growing number of blood cancer patient and the high cost of drugs used for the treatment of blood cancer. By Application Gastrointestinal cancer Blood cancer Prostate cancer Skin cancer Respiratory/lung cancer Breast cancer Other types of cancers By Products & Services Immunotherapy (biologics therapy) Hormonal therapy Targeted therapy Chemotherapy Others

  3. Inquiry before Buying @ https://www.alexareports.com/send-an-enquiry/9274 By Region North America • USA • Canada Europe • Germany • U.K. • France • Italy • Rest of Europe APAC • China • India • Japan • Rest of Asia-Pacific RoW • Latin America • Middle East & Africa Table of Content 1. Introduction 2. Research Methodology

  4. 3. Executive Summary 4. Industry Overview 5. Industry Trends 6. Oncology/ Cancer Drug Industry by Products & Services 7. Oncology/ Cancer Drugs Industry by Application Ask For Discount @ https://www.alexareports.com/check-discount/9274 8. Geographical Analysis 9. Company Profiles (A brief overview of another 13 companies is also provided) 11. Competitive Analysis 11.1. Introduction 11.2. Industry Positioning of Key Players 11.3 Competitive Strategies Adopted by Leading Players 11.3.1. Investments & Expansions 11.3.2. New Product Launches 11.3.3. Mergers & Acquisitions 11.3.4. Agreements, Joint Ventures, and Partnerships 12. Appendix 12.1. Questionnaire 12.2. Available Customizations 12.3. Upcoming Events (Trade Fair, Exhibitions, Conferences)

  5. Buy Now @ https://www.alexareports.com/checkout/9274 About Us: Alexa Reports is a globally celebrated premium market research service provider, with a strong legacy of empowering business with years of experience. We help our clients by implementing decision support system through progressive statistical surveying, in-depth market analysis, and reliable forecast data. Alexa Reports is a globally celebrated premium market research service provider, with a strong legacy of empowering business with years of experience. We help our clients by implementing decision support system through progressive statistical surveying, in-depth market analysis, and reliable forecast data. Contact Us: Alexa Reports Ph no: +1-408-844-4624 / +91- 7030626939 Email: sales@alexareports.com Site: https://www.alexareports.com https://www.linkedin.com/company/alexa-report https://www.facebook.com/alexareportsinc https://twitter.com/Alexa_Reports

More Related